
Conference Coverage
Latest News

From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes

Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder

RSV May Complicate Multiple Myeloma Care Through Therapy Delays, Not Mortality Risk

COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics

Optimizing Isotretinoin Therapy: Conventional Regimens and New Approaches

Shorts










Podcasts
Videos
Continuing Medical Education
All News

A groundbreaking vaccine shows 73% efficacy against Salmonella Paratyphi A, offering hope in combating enteric fever globally.

Explore the risks of synthetic 7-hydroxymitragynine (7-OH) products and why natural leaf kratom is a safe alternative.

Berberine is increasingly used for weight management despite limited supporting evidence, emphasizing the need for pharmacist-led education, interaction monitoring, and adverse effect counseling.

Although the incidence of vascular assess-associated infections (VAIs) was low, the incidence caused by noncuffed catheters (NCC) was high.

A retrospective chart review demonstrates the safety of using monoclonal antibodies that are produced with Chinese hamster ovary cells in patients with an allergy to alpha gal.

Continuous glucose monitoring (CGM) significantly enhances the detection of cystic fibrosis-related diabetes, outperforming traditional methods.

Researchers explore HER3-targeted therapy with patritumab deruxtecan to enhance outcomes in early-stage triple-negative breast cancer, reducing chemotherapy side effects.

Research reveals a notable risk of invasive fungal infections in multiple myeloma patients undergoing BCMA-targeted CAR T-cell therapy, highlighting the need for vigilant monitoring.

Explore how pharmacist-led long-acting injectables (LAIs) enhance medical adherence for schizophrenia patients, improving care transitions and outcomes.

Influenza significantly impacts agricultural workers in the Americas, highlighting urgent vaccination needs for public health and food security.

Steps must be made to preserve pharmacy access for those who need it most.

The FDA designates Stoboclo and Osenvelt as interchangeable biosimilars for denosumab, enhancing treatment options for osteoporosis and cancer-related conditions.

Low RSV vaccination rates among older adults in the US highlight missed opportunities for reducing hospitalizations and health care costs.

Long-term benzodiazepine use has been linked to lasting cognitive impairments, underscoring the vital role pharmacists play in supporting safe deprescribing strategies.

The 20-valent pneumococcal conjugate vaccine (PCV20) demonstrated higher vaccine effectiveness against invasive pneumococcal disease or all-cause pneumonia in cohorts of older adults.

New strategies target dormant tumor cells in breast cancer, offering hope for preventing recurrence and transforming patient management.

Pharmacy students in Pakistan confront antibiotic misuse, highlighting urgent need for stewardship to combat antimicrobial resistance and protect public health.

FDA designates Conexxence and Bomyntra as interchangeable denosumab biosimilars, enhancing access and affordability for patients needing critical therapies.

Pharmacists play a vital role in vaccine education and administration.

FDA accelerated approval speeds access but faces challenges with trial completion, costs, and end point validation.

Explore how the NCC MERP Severity Index transforms medication error reporting, enhancing safety and prevention strategies in healthcare systems.

As cellular and bispecific immunotherapies move into earlier treatment lines, pharmacists are interpreting new guidelines, managing toxicities, and shaping patient care strategies.

Environmental factors significantly influence the rising rates of type 2 diabetes in children.




































